Target intelligence / Profile preview

Neuronal and mitochondrial phospholipid membranes

Molecular classification
Lipid bilayer, Cellular structure, Organelle membrane
01

Overview

Neuronal and mitochondrial phospholipid membranes are critical structural and functional components of the nervous system, providing the scaffold for signal transduction and energy production. These membranes are composed of a complex bilayer of phospholipids, cholesterol, and proteins that maintain cellular homeostasis and facilitate communication between neurons (Escribá et al., 2015, J. Cell. Mol. Med.). In many neurodegenerative and mitochondrial disorders, the composition and fluidity of these membranes are compromised, leading to impaired mitochondrial function, increased oxidative stress, and eventual cell death (Sabbah, 2016, PubMed). Therapeutic strategies, often referred to as membrane lipid therapy or melitherapy, aim to restore the healthy lipid architecture of these membranes to improve neuronal survival and metabolic efficiency (Pizcueta et al., 2020, Neurotherapeutics). Drugs targeting these structures, such as elamipretide, often work by stabilizing the lipid bilayer, specifically interacting with phospholipids like cardiolipin to enhance mitochondrial bioenergetics. By protecting the integrity of these membranes, these interventions seek to mitigate the progression of diseases like Alzheimer's and X-linked adrenoleukodystrophy.

Other names
Neuronal lipid bilayerMitochondrial lipid bilayerNerve cell membranesMitochondrial inner and outer membranes
02

Mechanism of action

Modulation of membrane fluidity and lipid composition to restore cellular signaling and mitochondrial bioenergetics (Escribá et al., 2015, J. Cell. Mol. Med.).

03

Biological functions

Signal transductionEnergy metabolismApoptosis regulationIon transportStructural integrity
04

Disease associations

Neurodegenerative diseaseMitochondrial diseaseX-linked adrenoleukodystrophyFriedreich's ataxiaAlzheimer's disease
05

Safety considerations

Systemic lipid metabolism disruptionOff-target membrane effectsPotential for lipotoxicity
06

Interacting drugs

Elamipretide

4 more in the full profile.

07

Biomarkers

Lipidomic profileNeurofilament light chain (NfL)8-hydroxy-2'-deoxyguanosine (8-OHdG)Mitochondrial DNA (mtDNA) copy number

Beyond the preview

Go deeper on Neuronal and mitochondrial phospholipid membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal and mitochondrial phospholipid membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call